New study shows COVID infection weakens immune-cell response to vaccination
LOS ANGELES, March 20 (Xinhua) -- The magnitude and quality of a key immune cell's response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people without prior infection, according to a new study published on Monday.
The study, co-funded by the U.S. National Institutes of Health, also found the level of this key immune cell that targets the SARS-CoV-2 spike protein was substantially lower in unvaccinated people with COVID-19 than in vaccinated people who had never been infected.
The study, published in the journal Immunity, suggests that the virus damages important immune-cell response.
The new findings highlight the need to develop vaccination strategies to specifically boost antiviral CD8+ T cell responses in people previously infected with SARS-CoV-2, according to the researchers.
Photos
Related Stories
- Expert says COVID lab leak theory "purely politically motivated"
- How China contributed to global anti-COVID fight, economic recovery
- China's COVID-19 response completely right, highly effective: premier
- Unequal access to COVID-19 vaccines causes preventable deaths: open letter
- Long COVID may cause surge in U.S. women with disabilities: media
Copyright © 2023 People's Daily Online. All Rights Reserved.